Skip to main content
Fig. 2 | BMC Medical Imaging

Fig. 2

From: Patterns of use, effectiveness and safety of gadolinium contrast agents: a European prospective cross-sectional multicentre observational study

Fig. 2

Liver lesion pre and post administration of contrast. Liver lesion pre and post administration of contrast. Middle-aged woman (45–65 year old category) with a history of breast cancer, treated with mastectomy and chemotherapy in 2001 and ovarian cancer in 2011 treated with surgery (hysterectomy and double adnexectomy). a The follow-up study in 2019 identifies a hypointense liver lesion (arrow) in T1 without contrast and b after the administration of contrast (Clariscan, 0.10 mmol/kg), in the arterial phase of the dynamic study, shows peripheral uptake. After partial hepatectomy, liver metastasis of high-grade ovarian serous-papillary carcinoma is confirmed. Image quality was reported as good by site investigator. Images from Hospital Universitario del Henares, Spain

Back to article page